Meloxicam; Rizatriptan Benzoate Patent Expiration
Meloxicam; Rizatriptan Benzoate was first introduced by Axsome Therapeutics Inc
Meloxicam; Rizatriptan Benzoate Patents
Given below is the list of patents protecting Meloxicam; Rizatriptan Benzoate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Symbravo | US12128052 | Pharmaceutical compositions comprising meloxicam | May 28, 2040 | Axsome |
| Symbravo | US10029010 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10058614 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10137131 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10195278 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10265324 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10363312 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10369224 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10426839 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10463736 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10471014 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10471069 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10512692 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10512693 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10517950 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10532101 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10537642 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10561664 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10583144 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10653777 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10688102 | Combination treatment for migraine and other pain | Apr 11, 2036 | Axsome |
| Symbravo | US10688185 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10695429 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10695430 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10702535 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10702602 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10722583 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10729696 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10729697 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10729773 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10758617 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10758618 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10780165 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10780166 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10799588 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10821181 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10821182 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10894053 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10905693 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10918722 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10933136 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10933137 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10940153 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US10987358 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11013805 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11013806 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11020483 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11045549 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11135295 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11207328 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11219626 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11285213 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11331323 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11369684 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11426414 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11471464 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11471465 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11504429 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11510927 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11571428 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11602563 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11607456 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11617755 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11617756 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11617791 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11628173 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11712441 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11738085 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11759522 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11801250 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11806354 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11826370 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US11865117 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
| Symbravo | US9821075 | Pharmaceutical compositions comprising meloxicam | Apr 11, 2036 | Axsome |
Meloxicam; Rizatriptan Benzoate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List